T cell-targeting nanoparticles focus delivery of immunotherapy to improve antitumor immunity
Targeted delivery of immunomodulatory compounds to defined subsets of endogenous immune cells may improve the efficacy of combination immunotherapies. Here, the authors use PD-1-targeting nanoparticles containing a TGFβ inhibitor or a TLR7/8 agonist to deliver these payloads to T cells or via T cell...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Nature Portfolio
2017
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/08f1cc43b00d4985af2f7a6446427a7e |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|